X-group (possible homology)

1002 Fluoride ion channel

Ligands and drugs

567
Member domains
38
with ligand contacts (≤ 4 Å)
6.7% of members
38
with DrugDomain annotations
6.7% of members
1
with a DrugBank compound
0.2% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

3
Proteins with classified ligands
3
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Lipids and lipid-like molecules30.39.11×not tested
Homogeneous non-metal compounds30.64.71×not tested
Homogeneous metal compounds11.50.69×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

No DrugBank compounds are annotated on this group's domains.

Most frequently bound compounds

PDB ligandNameDomains in contact
NAmetalSODIUM ION34
FFLUORIDE ION30
DMUDECYL-BETA-D-MALTOPYRANOSIDE26
BRBROMIDE ION10
HGmetalMERCURY (II) ION4
OLC(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate2